Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Financial Results
Aratana Therapeutics reported a 53% drop in sales to $4.9 million during the fourth quarter of 2018, due to a large one-off payment made last year.
Early-stage Canadian firm Avivagen has posted a sturdy growth in sales in the first quarter of 2019.
Kindred BioSciences has reported sales of $1.3 million in the fourth quarter of 2018, around five months after commercializing its lead product.
Perrigo's animal health business has reported an annual sales decline for the fourth year in a row.
Brazil's Ouro Fino Saúde Animal has maintained its comeback with 8% sales growth in the fourth quarter of 2018.
Zomedica Pharmaceuticals' net loss doubled in 2018 on the back of a heavy R&D focus throughout the year.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.